Matrix Biomed
CA - IrvineBiotechnology
Focus: Matrix Biomed is a gene therapy biotech focused on oncology, developing novel treatments for various cancers including prostate cancer, glioblastoma, and other malignancies. The company operates as a pre-revenue stage biotech headquartered in Irvine, California.
Profile data last refreshed 1h ago · AI intelligence enriched 1w ago
Open Jobs
3
Should You Work at Matrix Biomed?
AI assessmentMatrix Biomed is a high-risk, high-reward gene therapy startup best suited for early-career scientists or commercial professionals willing to build infrastructure from scratch with uncertain funding visibility.
Why Work Here
- Early-stage gene therapy platform with 6 active clinical programs across multiple cancer indications, offering exposure to cutting-edge oncology science.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
6 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
MBM-02
Prostate CancerClinical Trials (1)
NCT04337099A Single Patient Compassionate Use of MBM-02 (Tempol) for the Treatment of Prostate Cancer
N/AHelp build intelligence for Matrix Biomed
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.